Skip to main content
. Author manuscript; available in PMC: 2007 Nov 1.
Published in final edited form as: Alcohol Clin Exp Res. 2007 Mar 31;31(5):829–836. doi: 10.1111/j.1530-0277.2007.00381.x

Table 2.

Adjusted Mean Differences in CD4 Cell Count, Log10 HIV RNA, and Percent CD4 Cells from Longitudinal Regression Models Comparing HCV RNA-Positive Subjects Versus HCV RNA-Negative Subjects According to ART Status

CD4 cell counta
 Log10 HIV RNAb
 Percent CD4 cellsc
ART status HCV status Adjusted mean difference (SE)d p-Value Adjusted mean difference (SE)d p-Value Adjusted mean difference (SE)d p-Value
Adherent to ART HCV RNA+ -46.0 (21) 0.03 0.086 (.12) 0.46 -2.3 (.76) <0.01
HCV RNA- — — —
Not adherent to ART HCV RNA+ -4.5 (28) 0.88 -0.010 (0.16) 0.96 -1.3 (1.0) 0.18
HCV RNA- — — —
Not on ART HCV RNA+ -16.3 (23) 0.48 0.23 (0.13) 0.08 -0.48 (0.84) 0.57
HCV RNA- — — —

Bold font indicates significant differences (p<0.05).

a

Analyses based on 344 subjects and 1,171 observations.

b

Analyses based on 395 subjects and 1,542 observations.

c

Analyses based on 341 subjects and 1,160 observations.

d

All analyses adjusted for: ART status, interaction between HCV status and ART status, gender, age, race, homelessness, participation in previous HIV cohort study, alcohol consumption, drug dependence diagnosis, injection drug use past 6 mo, time, and baseline value of the outcome (CD4 cell count analyses only).

HIV, human immunodeficiency virus; ART, antiretroviral therapy.